You have read all your free articles, to continue reading subscribe to read the rest of this content.
Calliditas Therapeutics has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the granting of a conditional marketing authorisation for Kinpeygo for the treatment of primary immunoglobulin A (IgA) nAlready a subscriber Login You have read all…
Exact Therapeutics has announced that its collaboration partner GE Healthcare has been awarded with an innovation grant from the Norwegian Research Council (NRC) of 16 million NOK to support the development of a ready-to-use formulation of Sonazoid for ultrasound imaging and therapy. “We are veAlready a subscriber Login You have…
The Roddenberry Foundation has announced the six awardees of its biennial 1.5 million USD Prize to support audacious early-stage science and technology ventures that contribute to the United Nations Development Goals (UN SDGs). The 2023 Grand Prize (1 MUSD) has been awarded to Elypta for their deAlready a subscriber Login…
Nordic Nanovector has raised MNOK 500 in gross proceeds through a private placement of 4,374,244 new shares. Nordic Nanovector intends to use the net proceeds to fund a Phase 2 combination study of Betalutin® and Rituximab CD20, fund a Phase 1 study and GMP manufacturing for 177Lu-conjugated cAlready a subscriber…
